about
Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC.IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer.(223)Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients.Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: Case report and review of the literature.Current and future therapeutic approaches for the treatment of small cell lung cancer.Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios.Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancerActivity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
P50
Q37725971-4665E0E9-D618-444A-B104-8EB46FF97B55Q38622786-FDED6A3A-788D-4A64-9B74-95996C983243Q40073452-9ECE2317-F91F-408F-A762-3E5210064913Q47422870-3C008940-62FC-4CB8-A73A-9D875F0A6CDAQ52608456-D46D699D-67E8-4890-A085-9A4CFC5B4454Q52653783-12CBB7E0-A1C3-49E8-BFD0-F74FE3E9F0CFQ55401509-D8C271DF-19A2-4857-AD2B-DD2CE8061032Q90354457-6E106E7F-597E-4A4C-ADAD-4C41330CDF2AQ90621386-AD09D978-C4B7-4BC3-B133-D3B43FAA73E5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Arsela Prelaj
@ast
Arsela Prelaj
@en
Arsela Prelaj
@es
Arsela Prelaj
@nl
type
label
Arsela Prelaj
@ast
Arsela Prelaj
@en
Arsela Prelaj
@es
Arsela Prelaj
@nl
prefLabel
Arsela Prelaj
@ast
Arsela Prelaj
@en
Arsela Prelaj
@es
Arsela Prelaj
@nl
P106
P1153
56087693700
P31
P496
0000-0002-3863-088X